Liam McDonnell, President

Liam McDonnell obtained an MCHEM in Chemistry from the University of Oxford, UK, and a PhD in Chemistry from the University of Warwick, UK. Following a post-doctoral researcher position at the FOM institute for Atomic and Molecular Physics in Amsterdam, he started his own research group at Leiden University Medical Center, where he is Associate Professor. He is director of Proteomics at the Fondazione Pisana per la Scienza, and Vice-President of the Mass Spectrometry Imaging Society.

Martina Marchetti-Deschmann, Vice President

Martina Marchetti-Deschmann (TU Wien, Institute of Chemical Technologies and Analytics) has been working in the field of Instrumental Bioanalytical Chemistry for more than 20 years with a special focus on mass spectrometry, separation sciences, biomolecule identification and detailed characterization. She is a well-known expert in proteomics, glycomics focussing on method development, future directing applications of mass spectrometry and instrument improvements. Since 2009 she has established MALDI mass spectrometric imaging in Austria and is an internationally recognized expert in the field building her capacities through European based networks and national collaborations in the fields of Life Sciences and Material Sciences. Current research is focused on 1) applying MALDI and DESI as soft ionization techniques for surface analysis in the field of MSI; 2) developing sample preparation strategies to gather omics information from sample surfaces and combine this strategy with classical LC-MS approaches; and 3) combining the emerging field of MS imaging with methodologies traditionally used in other fields, i.e. MRI, CT, PET, IR, Raman (medicine) or XRF, and AFM (material sciences), building a strong basis for new developments in multimodal imaging.

Markus Stoeckli, Treasurer

Markus obtained his Ph.D. in 1996 from the University of Berne on the subject of mass spectrometry instrument design. In 1998, after a year of postdoctoral research at the University of Texas in Houston, he joined the faculty of the Vanderbilt University as a research instructor in the field of biological mass spectrometry. He is one of the pioneers in the field of label-free molecular imaging by mass spectrometry and his current work focuses on biomedical applications of this and other novel technologies. In his latest project, he is measuring a multitude of protein distributions by imaging mass cytometry. Markus  is known for his engaged discussion of the scientific challenges in providing impact to biomedical research by developing adequate technologies. He is a co-founder of the mass spectrometric imaging society and a member of international grant review panels and thesis/habilitation committees.

Tiffany Porta Siegel, Communication

Tiffany is Assistant Professor at the Maastricht Multimodal Molecular Imaging Institute (M4I, Maastricht University, Netherlands). Her research focuses on translation between the development of innovative MS-based instrumentation and direct application to clinical research – with a special interest on intraoperative mass spectrometry. In particular, the use of molecular-based diagnostics – mostly based on lipid signatures – is expected to improve patient’s management during surgery and overall outcome. Since November 2016, she is part of the Chair Team of the European Molecular Imaging Meeting ESMI study group on MSI and actively contributes to the dissemination of MSI to other fields, and work towards the integration of MSI to other (molecular) imaging modalities. She is also Lead of the Scientific Committee of MSACL – The Association for Mass Spectrometry: Applications to the Clinical Lab. She is currently serving as the Communication officer on the board of the MSIS and actively contribute to communicate about activities (conference, workshops…) where MSI is involved.

Gérard Hopfgartner, Academia

Gérard Hopfgartner is full Professor for Analytical Sciences and Mass Spectrometry in the Department of Analytical and Inorganic Chemistry of the University of Geneva. His research interests focus around the development and application of novel mass spectrometry approaches with and without chromatography in the field of life sciences. His scientific interests include: hyphenation of separation sciences with MS, automation, bioanalysis, metabolism, metabolomics, analytical proteomics, ionization techniques, MS/MS fragmentation, ion mobility mass spectrometry and mass spectrometry imaging. He acts as an editor for Analytical Bioanalytical Chemistry and he is member of the scientific committee of the HPLC Conference Series.

Peter Marshall, Industrial link

After graduating from the University of Hull in 1984 Peter did a PhD at the University of Reading in collaboration with ICI Plant Protection Division (now Syngenta) at Jealott’s Hill, Berkshire. He joined Glaxo (now GlaxoSmithKline) in February 1988 as a Natural Product Extraction Chemist before moving into the mass spectrometry group in 1993. His many roles included the development of methodologies for analysing compounds from single resin beads as part of the combinatorial chemistry era. This work also included the use of Inductively Coupled Plasma mass spectrometry (ICP-MS) which led us into MALDI MS imaging about 12 years ago. Peter pioneered the introduction of MALDI MS Imaging into GSK and was an active member of the recent European Union Cooperation in Science and Technology (COST) Action for MALDI MS Imaging representing the UK. In this capacity, Peter was instrumental in organising and co-running several workshops for the advancement of techniques for On-Tissue Digestion prior to MALDI Imaging analysis. Peter was part of the original Team that helped co-found the Mass Spectrometry Imaging Society (MSIS) and is currently serving as the Industrial Link on the board of the MSIS. Peter’s use of MALDI MS Imaging has recently morphed into Ultra High Throughput Screening by MALDI and through a collaboration between GSK, Bruker and Analytik Jena/Cybio has led to the development of a fully Automated system that has the potential to spot and analyse a full diversity 2 million compound assay in ~8 days.

Ann-Christin Niehoff, Initiatives

Ann-Christin Niehoff studied Chemistry at the University of Münster, Germany and finished her Master of Science Chemistry in 2013. Her thesis focused on elemental bioimaging of metal-tagged drug delivery systems by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS). During her PhD, she performed complementary imaging using MALDI-MS for molecular, and LA-ICP-MS for elemental imaging. Analysis has been performed on different samples such as tumor spheroids, rat brain sections and human brain tumors. Furthermore, multimodal analysis with magnetic resonance imaging (MRI) were carried out. She finished 2016 her PhD at the University of Münster, Germany in the research group of Prof. Uwe Karst and received for her thesis the Wolfgang Paul Study Award from the German Society of Mass Spectrometry (DGMS) as well as the DAAS Award from the work group Analytical Spectroscopy of the German Society of Chemistry. Dr. Niehoff is currently working at Shimadzu Europa GmbH, Duisburg, Germany, for the European Innovation Center – Imaging. The focus of her work is to establish collaborations with scientific researchers for the development of new applications and technologies in the field of imaging.

Garry Corthals, Outreach

Malcolm Clench


Ron Heeren, Past president (2018)

Ron obtained a PhD degree in technical physics in 1992 at the University of Amsterdam on plasma-surface interactions. He was the research group leader at FOM-AMOLF for macromolecular ion physics and biomolecular imaging mass spectrometry. In 2001 he was appointed professor at the chemistry faculty of Utrecht University lecturing on the physical aspects of biomolecular mass spectrometry. In the period 1995-2015 he has been developing new approaches towards high spatial resolution and high throughput molecular imaging mass spectrometry using Secondary Ion Mass Spectrometry and Matrix Assisted Laser Desorption and Ionization. He was the research director for emerging technologies within the Netherlands Proteomics Centre from 2008-2013. In 2012 he co-founded Omics2Image B.V., a company focused on bringing innovative ion detector technology to the analytical market. In 2014 he was appointed as distinguished professor and Limburg Chair at the University of Maastricht. He is one of the scientific directors of M4I, the Maastricht MultiModal Molecular Imaging institute and heads the division of imaging MS. He is the elected treasurer and executive board member of the international mass spectrometry foundation and serves on various editorial boards of peer-reviewed journals. He is and has been active in many professional societies to advance mass spectrometric research, education and professionalization. His publication record encompasses an excess of 200 peer-reviewed publications and his H-index is 38. His academic research interests are the fundamental studies of the energetics of macromolecular systems, conformational studies of non-covalently bound protein complexes, translational imaging research, high-throughput bioinformatics and the development and validation of new mass spectrometry based proteomic imaging techniques for the life sciences.